Frank Verbeeck M.D.

Frank Verbeeck MD is a seasoned professional in the pharmaceutical and clinical research sectors, currently serving as Head of Medical Science and Clinical Development at Zambon since May 2024, where responsibilities include leading medical teams and establishing frameworks for compliant clinical research initiatives. Concurrently, Frank holds the position of Chief Medical Officer at Arega Pharma, focusing on medical affairs and scientific business development since September 2019, and serves as a Non-Executive Board Member for Clinitude, a global clinical CRO specializing in oncology and medical devices. Frank's previous roles include Senior Global Program Clinical Head at Novartis and Vice President of Clinical Development at Galapagos, along with notable management positions at Astellas Pharma Europe and Bristol-Myers Squibb, demonstrating extensive expertise in medical management, clinical operations, and strategic development. Frank obtained a Medical Doctor degree from Vrije Universiteit Brussel, with additional specialization in Clinical Pathology.